Non-syndromic uterovaginal malformation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:180065
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Non-syndromic uterovaginal malformation refers to a group of congenital anomalies affecting the development of the uterus and/or vagina that occur in isolation, without the additional features seen in syndromic conditions such as Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type 2 or other multi-system disorders. These malformations arise from abnormal development of the Müllerian (paramesonephric) ducts during embryogenesis and can include a wide spectrum of anomalies such as uterine agenesis, vaginal agenesis, uterine septum, bicornuate uterus, unicornuate uterus, uterus didelphys, or obstructive vaginal anomalies. The reproductive system is the primary body system affected, though secondary consequences may involve the urinary tract in some cases. Clinically, these malformations may present at puberty with primary amenorrhea (absence of menstruation), cyclic pelvic pain due to obstructed menstrual flow, or may remain undetected until difficulties with sexual intercourse or infertility arise in adulthood. Some patients are diagnosed incidentally during imaging for other reasons. The severity of symptoms depends on the specific type and degree of the malformation. Diagnosis typically involves pelvic ultrasound, MRI, and sometimes hysteroscopy or laparoscopy for definitive characterization. Treatment is tailored to the specific malformation and the patient's symptoms and reproductive goals. Surgical interventions may include vaginoplasty (creation or reconstruction of the vagina), hysteroscopic resection of uterine septa, or other reconstructive procedures. Non-surgical vaginal dilation therapy (such as the Frank method) is often a first-line approach for vaginal agenesis. Assisted reproductive technologies may be considered for patients with fertility challenges. Psychological support is also an important component of care, as these conditions can significantly impact quality of life and emotional well-being.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Non-syndromic uterovaginal malformation.

View clinical trials →

No actively recruiting trials found for Non-syndromic uterovaginal malformation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Non-syndromic uterovaginal malformation community →

No specialists are currently listed for Non-syndromic uterovaginal malformation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Non-syndromic uterovaginal malformation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Non-syndromic uterovaginal malformationForum →

No community posts yet. Be the first to share your experience with Non-syndromic uterovaginal malformation.

Start the conversation →

Latest news about Non-syndromic uterovaginal malformation

No recent news articles for Non-syndromic uterovaginal malformation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Non-syndromic uterovaginal malformation

What is Non-syndromic uterovaginal malformation?

Non-syndromic uterovaginal malformation refers to a group of congenital anomalies affecting the development of the uterus and/or vagina that occur in isolation, without the additional features seen in syndromic conditions such as Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type 2 or other multi-system disorders. These malformations arise from abnormal development of the Müllerian (paramesonephric) ducts during embryogenesis and can include a wide spectrum of anomalies such as uterine agenesis, vaginal agenesis, uterine septum, bicornuate uterus, unicornuate uterus, uterus didelphys, or obst